학술논문
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology November 2022 10(11):774-785
Subject
Language
ISSN
2213-8587